DEVELOPMENT AND VALIDATION OF STABILITY INDICATING REVERSE PHASE-LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND METOPROLOL SUCCINATE IN BULK AND IN TABLET DOSAGE FORM

PATIL V.K.1, GAWAD J.B.2, MHASKE A.J.3, PATIL K.D.4
1Post Graduate Dept. of Pharmaceutical Chemistry, R.C. Patel Inst. of Pharmaceutical Education and Research, Shirpur- 425 405, MS, India.
2Post Graduate Dept. of Pharmaceutical Chemistry, R.C. Patel Inst. of Pharmaceutical Education and Research, Shirpur- 425 405, MS, India.
3Post Graduate Dept. of Pharmaceutical Chemistry, R.C. Patel Inst. of Pharmaceutical Education and Research, Shirpur- 425 405, MS, India.
4Post Graduate Dept. of Pharmaceutics, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur- 425 405, MS, India.

Received : 05-11-2013     Accepted : 03-12-2013     Published : 24-12-2013
Volume : 2     Issue : 1       Pages : 14 - 18
Bioinfo Pharm Biotechnol 2.1 (2013):14-18

Cite - MLA : PATIL V.K., et al "DEVELOPMENT AND VALIDATION OF STABILITY INDICATING REVERSE PHASE-LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND METOPROLOL SUCCINATE IN BULK AND IN TABLET DOSAGE FORM." BIOINFO Pharmaceutical Biotechnology 2.1 (2013):14-18.

Cite - APA : PATIL V.K., GAWAD J.B., MHASKE A.J., PATIL K.D. (2013). DEVELOPMENT AND VALIDATION OF STABILITY INDICATING REVERSE PHASE-LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND METOPROLOL SUCCINATE IN BULK AND IN TABLET DOSAGE FORM. BIOINFO Pharmaceutical Biotechnology, 2 (1), 14-18.

Cite - Chicago : PATIL V.K., GAWAD J.B., MHASKE A.J., and PATIL K.D. "DEVELOPMENT AND VALIDATION OF STABILITY INDICATING REVERSE PHASE-LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND METOPROLOL SUCCINATE IN BULK AND IN TABLET DOSAGE FORM." BIOINFO Pharmaceutical Biotechnology 2, no. 1 (2013):14-18.

Copyright : © 2013, PATIL V.K., et al, Published by Bioinfo Publications. This is an subscription based article distributed under the terms of the Creative Commons Attribution License, in which, you may not use the material for commercial purposes, you may not distribute the modified material.

Abstract

A rapid, precise and specific stability indicating high performance liquid chromatography (RP-HPLC) method was developed for olmesartan medoxomil (OM) and metoprolol succinate (MS). The assay involves the isocratic elution of olmesartan medoxomil and metoprolol succinate in Phenomenex Gemini C18 using mobile phase composition methanol: water (pH 3) in the ratio of 55:45 (v/v). The wavelength of detection is 236 nm. The proposed method can be used for routine quality control in bulk and in dosage forms. The method can also be applied for the stability studies as it separates the constitutions from its degradation products. Retention time of olmesartan medoxomil and metoprolol succinate was found to be 7.9 and 3.4 min, respectively. Linearity was studied in the concentration range of 5 to 25 μg/mL and 15 to 75 μg/mL for olmesartan medoxomil and metoprolol succinate respectively, with a correlation coefficient of 0.999 and 0.997 respectively. The newly developed method was validated according to the ICH guidelines. The stability indicating studies shows the stability of both drugs towards oxidative stress and light; whereas degrades in both acidic and basic conditions.